Alphatec Holdings (ATEC) Asset Writedowns and Impairment (2010 - 2026)
Alphatec Holdings (ATEC) reported Asset Writedowns and Impairment of $3.6 million for Q1 2026, up 1.26% on a YoY basis from $3.6 million in Q1 2025, and up 63.47% sequentially from $2.2 million in Q4 2025.
Alphatec Holdings (ATEC) Asset Writedowns and Impairment (2010 - 2026) Analysis & Trends
Alphatec Holdings (ATEC) has 17 years of Asset Writedowns and Impairment data on file, last reported at $3.6 million in Q1 2026.
- For the quarter ending Q1 2026, Asset Writedowns and Impairment rose 1.26% year-over-year to $3.6 million; the trailing twelve-month figure through Mar 2026 stood at $13.6 million (down 15.08% YoY), and the FY2025 full-year result was $13.5 million, down 12.11% from the prior year.
- Asset Writedowns and Impairment rose to $3.6 million in Q1 2026, from $2.2 million in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $4.6 million in Q2 2023 to a low of $1.7 million in Q1 2022.
- A 5-year average of $3.3 million and a median of $3.4 million in 2025 frame the typical range for Asset Writedowns and Impairment.
- Across the five-year window, Asset Writedowns and Impairment soared 93.65% in 2023 and tumbled 50.07% in 2025, its largest moves.
- Tracing ATEC's Asset Writedowns and Impairment over 5 years: stood at $2.8 million in 2022, then surged by 59.62% to $4.4 million in 2023, then climbed by 0.23% to $4.4 million in 2024, then plunged by 50.07% to $2.2 million in 2025, then surged by 63.47% to $3.6 million in 2026.
- Business Quant data shows ATEC's Asset Writedowns and Impairment at $3.6 million in Q1 2026, $2.2 million in Q4 2025, and $3.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.33 Bn | 174.04 Bn | 6.27 Bn |
| 2 | Stryker | 128.11 Bn | 125.23 Bn | 3.81 Bn |
| 3 | Medtronic | 107.76 Bn | 98.54 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.95 Bn | 66.50 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.43 Bn | 26.14 Bn | 1.98 Bn |
| 7 | Dexcom | 28.31 Bn | 27.20 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.77 Bn | 26.19 Bn | - |
| 9 | Koninklijke Philips | 25.33 Bn | 22.21 Bn | 2.07 Bn |
| 10 | Alphatec Holdings | 1.35 Bn | 1.21 Bn | 136.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.62 Mn |
| Mar 31, 2026 | 3.62 Mn |
| Dec 31, 2025 | 2.21 Mn |
| Dec 31, 2025 | 2.21 Mn |
| Sep 30, 2025 | 3.38 Mn |
| Sep 30, 2025 | 3.38 Mn |
| Jun 30, 2025 | 4.37 Mn |
| Jun 30, 2025 | 4.37 Mn |
| Mar 31, 2025 | 3.57 Mn |
| Mar 31, 2025 | 3.57 Mn |
| Dec 31, 2024 | 4.43 Mn |
| Dec 31, 2024 | 4.43 Mn |
| Sep 30, 2024 | 4.11 Mn |
| Sep 30, 2024 | 4.11 Mn |
| Jun 30, 2024 | 3.88 Mn |
| Jun 30, 2024 | 3.88 Mn |
| Mar 31, 2024 | 2.98 Mn |
| Mar 31, 2024 | 2.98 Mn |
| Dec 31, 2023 | 4.42 Mn |
| Dec 31, 2023 | 4.42 Mn |